Your healthcare provider may have recently recommended, or might be recommending, that you switch to a generic version of Revlimid (lenalidomide). This is because on Sept. 1, 2021 new generic versions of lenalidomide capsules – commonly used for the treatment of multiple myeloma – were approved. Join Myeloma Canada to learn more about generic drugs and how they’re tested and reviewed in Canada.

Presented by: Mena Kinal, Pharmacist, Pharmacie Michael Assaraf (Montreal, QC)

Tuesday, November 30, 2021
11 a.m. MST / 1 p.m. EST

Join this webinar from the comfort of your own home. Register >>